Noninvasive Prenatal Testing (NIPT): Risks & Benefits
Noninvasive prenatal testing (NIPT) screens for genetic conditions in the fetus using a maternal blood sample. It provides information on fetal chromosomes and risk of certain genetic disorders.
Common NIPT Tests
- Cell-free DNA (cfDNA) testing: Analyzes placental DNA fragments in maternal blood. Assesses risk of chromosomal abnormalities (Down syndrome, trisomy 18).
- Maternal serum screening: Measures substances (AFP, hCG) in maternal blood. Assesses chromosomal abnormalities and neural tube defects (spina bifida).
- Combined screening: Combines cfDNA and serum screening for more accurate risk assessment.
Important Considerations
NIPT is safe and accurate as a screening test, but not diagnostic. If results indicate increased risk, diagnostic tests (amniocentesis, chorionic villus sampling) may be recommended for confirmation.
Pregnancy & Health - Related Articles
- Missed Period After Tubal Ligation: Pregnancy Risk and Next Steps
- Conception Date Estimation from Due Date: July 29 Example
- Conception Date from 14-Week Ultrasound: How to Calculate
- Spotting at 24 Weeks Pregnant: Causes & When to Call Your Provider
- Early Pregnancy Testing: Can You Test 5 Days Before a Missed Period?
- Pregnancy and Intercourse: Understanding Fertilization and Conception
- 15 Nutrient-Dense Foods for a Healthy Pregnancy
